《中国期刊全文数据库》收录期刊
《中国核心期刊(遴选)数据库》收录期刊
《中文科技期刊数据库》收录期刊

外科研究与新技术 ›› 2015, Vol. 4 ›› Issue (4): 223-225.

• 论著 • 上一篇    下一篇

结直肠癌中ADAM-9的表达与预后的关系

唐翀1,姜湉1,高雪松2,施文2,秦炜颜1,孙永强2   

  1. 1. 江苏省南通市第一人民医院
    2. 南通市第一人民医院
  • 收稿日期:2015-09-25 修回日期:2015-11-03 出版日期:2015-12-28 发布日期:2016-01-05
  • 通讯作者: 孙永强 E-mail:sunyq505@sina.com

  • Received:2015-09-25 Revised:2015-11-03 Online:2015-12-28 Published:2016-01-05

摘要: 目的:探讨结直肠癌组织中ADAM-9的表达及临床病理因素之间关系;并对病人进行术后随访,探讨ADAM-9表达与结直肠癌患者预后的关系。方法:应用免疫组化(IHC)检测不同临床分期的结直肠癌组织(72例)中ADAM-9的表达情况,并于正常组织对比。对术后所有病例患者进行电话随访,通过统计学计算分析探讨ADAM-9与结直肠癌患者预后的关系。结果: IHC结果显示,ADAM-9在正常组织中为阴性表达,在癌组织中为高表达,结直肠癌组中ADAM-9的阳性率为(69.44%,50/72)明显高于正常组织组(0%,0/10),结果具有统计学意义(P<0.05)。ADAM-9的表达与结直肠癌患者的性别、年龄、肿瘤大小、组织学类型均无统计学意义(P>0.05),与肿瘤侵犯深度、淋巴结转移,TNM分期,有统计学意义(P<0.05)。Kaplan-Meier生存分析显示,ADAM-9表达阳性表达的结肠腺癌患者术后生存期明显低于阴性表达者,差异有统计学意义(P<0.05)。结论:ADAM-9的表达情况与肿瘤TNM临床分期和浸润深度、有无淋巴结转移呈正相关,与结肠癌术后患者的复发时间呈负相关。提示ADAM-9可作为预测结肠癌生存期的指标,用于术后复发风险的评估。

关键词: 关键词:结直肠癌, ADAM-9, 预后

Abstract: Objective To study the expression of ADAM-9 in human’s colorectal cancer tissues and the relationship between ADAM-9 and the clinical pathological factors of colorectal cancer. Follow up the recurrence of patients with colorectal cancer after operation, research ADAM-9’s expression and the prognosis of colorectal cancer. Methods Colorectal cancer tissues (80 cases) and normal colorectal tissues (10 cases) were obtained from patients. ADAM-9 protein was measured by immunohistochemistry (Envision method), And in all cases the patients were followed up by telephone, by statistical calculation and analysis the relations between ADAM-9 and the recurrence of colorectal cancer. Results ADAM-9 mRNA were overexpresssed in cancer tissues and lowexpressed in normal tissues .The expression of ADAM-9 in colorectal carcinoma is associated with tumor TNM clinical stage and depth of invasion, lymph node metastasis which may be associated with the prognosis of gastric cancer(P<0.05). The expression of ADAM-9 in patients with patients' gender, age, tumor location, tumor size, histological type had no statistical significance (P>0.05).The survival time of patients with ADAM-9 positive was significantly lower than that of patients with negative expression (P<0.05). Conclusions ADAM-9 was overexpressed in colorectal cancer tissues and was related with tumor TNM clinical stage and depth of invasion, lymph node metastasis and the prognosis of colorectal cancer. ADAM-9 may be a prognostic indicator of colorectal cancer to assess recurrence risk in patients with colorectal cancer. Keywords: colorectal cancer,ADAM-9,prognosis